Back
Speaker illustration

Doctor Rafael Gonzalez-Manzanares

Reina Sofia University Hospital, Cordoba (Spain)

Member of:

European Society of Cardiology

Rafael Gonzalez-Manzanares is a cardiologist and clinical researcher with a special interest in heart failure, coronary artery disease, and cardio-oncology. He trained in medicine and cardiology at the University of Córdoba (Spain), holds a PhD in Biomedicine, and completed an MSc in Statistics at University College London (UK), with a focus on clinical research methodology. He is currently based at the Heart Failure and Transplant Unit of Reina Sofía University Hospital in Córdoba, and holds a physician-scientist Juan Rodés contract from the Instituto de Salud Carlos III (Madrid, Spain). His research focuses on the most prevalent contemporary cardiovascular diseases, particularly heart failure and coronary artery disease, as well as on more vulnerable populations, such as patients affected by the cardiotoxic effects of cancer therapies

Presentations Articles

Transcatheter mitral edge-to-edge repair in oncology patients: insights from the Spanish M-TEER registry

Event: ESC Cardio-Oncology 2025

Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer

Session: Young Investigator Award - Clinical Cardio-Oncology

Access
Like
Thumbnail

Transcatheter mitral edge-to-edge repair in patients with prior cancer diagnosis

Event: ESC Congress 2024

Topic: Cardio-Oncology

Session: Cardiovascular risk of cancer therapy

Access
Like
Thumbnail

Prevalence and incidence of heart failure in patients with type 2 diabetes mellitus. Results of the prospective DIABET-IC study

Event: ESC Congress 2024

Topic: Epidemiology

Session: Diabetes: a risk factor in heart disease

Access
Like
Thumbnail

Prevalence and incidence of heart failure in patients with type 2 diabetes mellitus. Results of the prospective DIABET-IC study

Event: Heart Failure 2024

Topic: Diabetes and the Heart

Session: Risk factors and prevention

Access
Like
Thumbnail

Optimization of pharmacological treatment of heart failure in patients followed in specialized HF units in Spain.

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: Chronic heart failure - treatment 7

Access
Like
Thumbnail

Differences in the optimization of pharmacological treatment in patients with heart failure and reduced ejection fraction and advanced chronic kidney disease.

Event: Heart Failure 2024

Topic: Comorbidities

Session: Chronic heart failure - comorbidities 1

Access
Like
Thumbnail

Incidence of 1-year mortality, heart failure admissions and decompensation in patients with heart failure followed in HF units in Spain. Differences according to type of units.

Event: Heart Failure 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic heart failure - epidemiology, prognosis, outcome 8

Access
Like
Thumbnail

Differences in the clinical features of patients with heart failure and reduced, mildly reduced, and preserved ejection fraction in a contemporary cohort in Spain: is the clinical profile changing?

Event: Heart Failure 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic heart failure - epidemiology, prognosis, outcome 4

Access
Like
Thumbnail

Global longitudinal strain assessment in long-term survivors of childhood acute lymphoblastic leukemia

Event: ESC Congress 2022

Topic: Tissue Doppler, Speckle Tracking and Strain Imaging

Session: Role of echocardiography in cardio-oncology

Access
Like
Thumbnail

An infrequent clinical presentation of a very rare coronary entity.

Event: ESC Congress 2021 - The Digital Experience

Topic: Percutaneous Coronary Intervention (PCI)

Session: Acute coronary syndromes in patients presenting without persistent ST-segment elevation

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources